151 related articles for article (PubMed ID: 18560151)
1. Structure of the recombinant antibody Fab fragment f3p4.
Frey D; Huber T; Plückthun A; Grütter MG
Acta Crystallogr D Biol Crystallogr; 2008 Jun; 64(Pt 6):636-43. PubMed ID: 18560151
[TBL] [Abstract][Full Text] [Related]
2. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
[TBL] [Abstract][Full Text] [Related]
3. The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment.
Schiweck W; Skerra A
J Mol Biol; 1997 May; 268(5):934-51. PubMed ID: 9180382
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of an enantioselective fab-fragment in free and complex forms.
Parkkinen T; Nevanen TK; Koivula A; Rouvinen J
J Mol Biol; 2006 Mar; 357(2):471-80. PubMed ID: 16427081
[TBL] [Abstract][Full Text] [Related]
5. Purification, crystallization and X-ray diffraction analysis of a recombinant Fab that recognizes a human blood-group antigen.
Song SC; Xie K; Czerwinski M; Spitalnik SL; Wedekind JE
Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):788-91. PubMed ID: 15039587
[TBL] [Abstract][Full Text] [Related]
6. N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties.
Saviranta PJauria P; Lamminmäki U; Hellman J; Eriksson S; Lövgren T
Protein Sci; 2000 Dec; 9(12):2547-56. PubMed ID: 11206076
[TBL] [Abstract][Full Text] [Related]
7. Comment on "Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydrates".
Lucas AH; Reason DC
J Immunol; 2009 May; 182(9):5160-1. PubMed ID: 19380755
[No Abstract] [Full Text] [Related]
8. Crystal parameters and molecular replacement of an anticholera toxin peptide complex.
Shoham M; Proctor P; Hughes D; Baldwin ET
Proteins; 1991; 11(3):218-22. PubMed ID: 1749774
[TBL] [Abstract][Full Text] [Related]
9. Fermenter production of an artificial fab fragment, rationally designed for the antigen cystatin, and its optimized crystallization through constant domain shuffling.
Schiweck W; Skerra A
Proteins; 1995 Dec; 23(4):561-5. PubMed ID: 8749852
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the 64M-2 antibody Fab fragment in complex with a DNA dT(6-4)T photoproduct formed by ultraviolet radiation.
Yokoyama H; Mizutani R; Satow Y; Komatsu Y; Ohtsuka E; Nikaido O
J Mol Biol; 2000 Jun; 299(3):711-23. PubMed ID: 10835279
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a cocaine-binding antibody.
Larsen NA; Zhou B; Heine A; Wirsching P; Janda KD; Wilson IA
J Mol Biol; 2001 Aug; 311(1):9-15. PubMed ID: 11469854
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
[TBL] [Abstract][Full Text] [Related]
13. Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loops.
Laffly E; Pelat T; Cédrone F; Blésa S; Bedouelle H; Thullier P
J Mol Biol; 2008 May; 378(5):1094-103. PubMed ID: 18423488
[TBL] [Abstract][Full Text] [Related]
14. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
15. Preliminary crystallographic study of a complex between an Fab of a monoclonal feline peritonitis virus neutralizing antibody and its anti-idiotypic Fab.
Ban N; Escobar C; Day J; Greenwood A; McPherson A
J Mol Biol; 1993 Dec; 234(3):894-6. PubMed ID: 8254683
[TBL] [Abstract][Full Text] [Related]
16. Preparation, crystallization and preliminary X-ray analysis of a complex between the Plasmodium vivax sexual stage 25 kDa protein Pvs25 and a malaria transmission-blocking antibody Fab fragment.
Saxena AK; Singh K; Long CA; Garboczi DN
Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2054-7. PubMed ID: 15502325
[TBL] [Abstract][Full Text] [Related]
17. An antibody library for stabilizing and crystallizing membrane proteins - selecting binders to the citrate carrier CitS.
Röthlisberger D; Pos KM; Plückthun A
FEBS Lett; 2004 Apr; 564(3):340-8. PubMed ID: 15111119
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and X-ray analysis of a single fab binding domain from protein L of Peptostreptococcus magnus.
Sohi MK; Wan T; Sutton BJ; Atkinson T; Atkinson MA; Murphy JP; Bottomley SP; Gore MG
Proteins; 1995 Dec; 23(4):610-2. PubMed ID: 8749861
[TBL] [Abstract][Full Text] [Related]
19. Structure of a monoclonal 2E8 Fab antibody fragment specific for the low-density lipoprotein-receptor binding region of apolipoprotein E refined at 1.9 A.
Trakhanov S; Parkin S; Raffaï R; Milne R; Newhouse YM; Weisgraber KH; Rupp B
Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):122-8. PubMed ID: 10089402
[TBL] [Abstract][Full Text] [Related]
20. Water channel in the binding site of a high affinity anti-methotrexate antibody.
Gayda S; Longenecker KL; Manoj S; Judge RA; Saldana SC; Ruan Q; Swift KM; Tetin SY
Biochemistry; 2014 Jun; 53(23):3719-26. PubMed ID: 24832237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
